Ajanta Pharma Ltd
NSE:AJANTPHARM

Watchlist Manager
Ajanta Pharma Ltd Logo
Ajanta Pharma Ltd
NSE:AJANTPHARM
Watchlist
Price: 2 803.75 INR -0.06%
Market Cap: 350.2B INR
Have any thoughts about
Ajanta Pharma Ltd?
Write Note

Intrinsic Value

The intrinsic value of one AJANTPHARM stock under the Base Case scenario is 1 935.13 INR. Compared to the current market price of 2 803.75 INR, Ajanta Pharma Ltd is Overvalued by 31%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

AJANTPHARM Intrinsic Value
1 935.13 INR
Overvaluation 31%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Ajanta Pharma Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
AJANTPHARM
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for AJANTPHARM cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about AJANTPHARM?
Bearish
Neutral
Bullish

Fundamental Analysis

2 803.75 INR
-0.06%
-0.06%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Ajanta Pharma Ltd
IN
Pharmaceuticals
Market Cap
350.2B INR
IPO
Jun 5, 2000
Employees
7 234
India
Market Cap
350.2B INR
Industry
Pharmaceuticals
IPO
Jun 5, 2000
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Ajanta Pharma Ltd

Provide an overview of the primary business activities
of Ajanta Pharma Ltd.

What unique competitive advantages
does Ajanta Pharma Ltd hold over its rivals?

What risks and challenges
does Ajanta Pharma Ltd face in the near future?

Has there been any significant insider trading activity
in Ajanta Pharma Ltd recently?

Summarize the latest earnings call
of Ajanta Pharma Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Ajanta Pharma Ltd.

Provide P/S
for Ajanta Pharma Ltd.

Provide P/E
for Ajanta Pharma Ltd.

Provide P/OCF
for Ajanta Pharma Ltd.

Provide P/FCFE
for Ajanta Pharma Ltd.

Provide P/B
for Ajanta Pharma Ltd.

Provide EV/S
for Ajanta Pharma Ltd.

Provide EV/GP
for Ajanta Pharma Ltd.

Provide EV/EBITDA
for Ajanta Pharma Ltd.

Provide EV/EBIT
for Ajanta Pharma Ltd.

Provide EV/OCF
for Ajanta Pharma Ltd.

Provide EV/FCFF
for Ajanta Pharma Ltd.

Provide EV/IC
for Ajanta Pharma Ltd.

Show me price targets
for Ajanta Pharma Ltd made by professional analysts.

What are the Revenue projections
for Ajanta Pharma Ltd?

How accurate were the past Revenue estimates
for Ajanta Pharma Ltd?

What are the Net Income projections
for Ajanta Pharma Ltd?

How accurate were the past Net Income estimates
for Ajanta Pharma Ltd?

What are the EPS projections
for Ajanta Pharma Ltd?

How accurate were the past EPS estimates
for Ajanta Pharma Ltd?

What are the EBIT projections
for Ajanta Pharma Ltd?

How accurate were the past EBIT estimates
for Ajanta Pharma Ltd?

Compare the revenue forecasts
for Ajanta Pharma Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Ajanta Pharma Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Ajanta Pharma Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Ajanta Pharma Ltd compared to its peers.

Compare the P/E ratios
of Ajanta Pharma Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Ajanta Pharma Ltd with its peers.

Analyze the financial leverage
of Ajanta Pharma Ltd compared to its main competitors.

Show all profitability ratios
for Ajanta Pharma Ltd.

Provide ROE
for Ajanta Pharma Ltd.

Provide ROA
for Ajanta Pharma Ltd.

Provide ROIC
for Ajanta Pharma Ltd.

Provide ROCE
for Ajanta Pharma Ltd.

Provide Gross Margin
for Ajanta Pharma Ltd.

Provide Operating Margin
for Ajanta Pharma Ltd.

Provide Net Margin
for Ajanta Pharma Ltd.

Provide FCF Margin
for Ajanta Pharma Ltd.

Show all solvency ratios
for Ajanta Pharma Ltd.

Provide D/E Ratio
for Ajanta Pharma Ltd.

Provide D/A Ratio
for Ajanta Pharma Ltd.

Provide Interest Coverage Ratio
for Ajanta Pharma Ltd.

Provide Altman Z-Score Ratio
for Ajanta Pharma Ltd.

Provide Quick Ratio
for Ajanta Pharma Ltd.

Provide Current Ratio
for Ajanta Pharma Ltd.

Provide Cash Ratio
for Ajanta Pharma Ltd.

What is the historical Revenue growth
over the last 5 years for Ajanta Pharma Ltd?

What is the historical Net Income growth
over the last 5 years for Ajanta Pharma Ltd?

What is the current Free Cash Flow
of Ajanta Pharma Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Ajanta Pharma Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Ajanta Pharma Ltd

Current Assets 27.9B
Cash & Short-Term Investments 7.6B
Receivables 10.4B
Other Current Assets 9.9B
Non-Current Assets 20B
Long-Term Investments 340m
PP&E 17.9B
Intangibles 133.2m
Other Non-Current Assets 1.7B
Current Liabilities 9.1B
Accounts Payable 4.2B
Other Current Liabilities 4.9B
Non-Current Liabilities 2B
Long-Term Debt 215.4m
Other Non-Current Liabilities 1.8B
Efficiency

Earnings Waterfall
Ajanta Pharma Ltd

Revenue
44.9B INR
Cost of Revenue
-10.9B INR
Gross Profit
34B INR
Operating Expenses
-22.7B INR
Operating Income
11.3B INR
Other Expenses
-2.6B INR
Net Income
8.8B INR

Free Cash Flow Analysis
Ajanta Pharma Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

AJANTPHARM Profitability Score
Profitability Due Diligence

Ajanta Pharma Ltd's profitability score is 67/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Year Average ROE
Positive 3-Year Average ROIC
67/100
Profitability
Score

Ajanta Pharma Ltd's profitability score is 67/100. The higher the profitability score, the more profitable the company is.

AJANTPHARM Solvency Score
Solvency Due Diligence

Ajanta Pharma Ltd's solvency score is 97/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Long-Term Solvency
Negative Net Debt
97/100
Solvency
Score

Ajanta Pharma Ltd's solvency score is 97/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AJANTPHARM Price Targets Summary
Ajanta Pharma Ltd

Wall Street analysts forecast AJANTPHARM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AJANTPHARM is 2 998.49 INR with a low forecast of 2 000.81 INR and a high forecast of 3 848.25 INR.

Lowest
Price Target
2 000.81 INR
29% Downside
Average
Price Target
2 998.49 INR
7% Upside
Highest
Price Target
3 848.25 INR
37% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for AJANTPHARM?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for AJANTPHARM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

AJANTPHARM Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More
What is the Intrinsic Value of one AJANTPHARM stock?

The intrinsic value of one AJANTPHARM stock under the Base Case scenario is 1 935.13 INR.

Is AJANTPHARM stock undervalued or overvalued?

Compared to the current market price of 2 803.75 INR, Ajanta Pharma Ltd is Overvalued by 31%.

Back to Top